COSCIENS Biopharma Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $6.2M | $22.0M |
| FY2017 | — | $-2.8M | $7.8M |
| FY2018 | — | $1.9M | $14.5M |
| FY2019 | — | $-2.5M | $7.8M |
| FY2020 | — | $13.2M | $24.3M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $6.2M | $22.0M |
| FY2017 | — | $-2.8M | $7.8M |
| FY2018 | — | $1.9M | $14.5M |
| FY2019 | — | $-2.5M | $7.8M |
| FY2020 | — | $13.2M | $24.3M |